BPL Medical Aims To Be The Strongest Player In India In Next Five Years

Express Healthcare speaks with Sunil Khurana, CEO & MD, BPL Medical Technologies, on the company’s growth plans and its vision for the Indian market.

- 

What is BPL’s vision for 2019?

BPL carries its legacy back to 1969 as the first Indian company to manufacture ECG device in India. BPL has always been a preferred noninvasive cardiology brand in the fraternity of medical practitioners whereby it has ECG Machines, defibrillators, stress test systems, cardiac analysers to offer to its customers. Today, we have evolved from being known as an ECG brand to one of the largest Indian medical devices company offering a wide range of products and solutions to our customers. Today, we operate across six product segments namely cardiology, critical care, women and child care, imaging, home care and consumables and accessories.

Our vision is to indigenise and manufacture more medical devices in India, and to transform the organisation as one of the largest Indian medical devices company. These equipment are designed keeping Indian patients and hospital ecosystems in mind with highest standards of radiation safety and user friendliness. Today, we operate across six product segments namely cardiology, critical care, women and child care, imaging, home care and consumables and accessories.

What is BPL’s current market share?

Different products have different market share. We have more like a 30 per cent in the ECG range, in ultrasound, our share is around five per cent since it is a new product. So, our market share could be in the range between 5 - 30 per cent.

What strategies will you adopt to meet your vision for this year?